AKT1 and cancer: Interestingly, in our current experiment, we observed that CDKN1A is enriched in various pathways, including those related to different types of cancers, Hepatitis B, Epstein-Barr virus infection, PI3K-Akt signaling pathway, p53 signaling pathway, and JAK-STAT signaling.